ClinVar Miner

Submissions for variant NM_000081.4(LYST):c.8806G>A (p.Val2936Ile)

gnomAD frequency: 0.00052  dbSNP: rs2753327
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 9
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV000629187 SCV000750103 uncertain significance Chédiak-Higashi syndrome 2022-10-24 criteria provided, single submitter clinical testing This sequence change replaces valine, which is neutral and non-polar, with isoleucine, which is neutral and non-polar, at codon 2936 of the LYST protein (p.Val2936Ile). This variant is present in population databases (rs2753327, gnomAD 0.1%), and has an allele count higher than expected for a pathogenic variant. This variant has not been reported in the literature in individuals affected with LYST-related conditions. ClinVar contains an entry for this variant (Variation ID: 525145). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt LYST protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
GeneDx RCV000658240 SCV000780011 uncertain significance not provided 2023-06-06 criteria provided, single submitter clinical testing Observed in a patient with primary platelet secretion defect; this individual also harbored variants in other possible causative genes (Gorski et al., 2019); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 30819905, 18485661, 27535533)
Fulgent Genetics, Fulgent Genetics RCV000629187 SCV000894771 uncertain significance Chédiak-Higashi syndrome 2021-08-10 criteria provided, single submitter clinical testing
Illumina Laboratory Services, Illumina RCV000629187 SCV001256311 uncertain significance Chédiak-Higashi syndrome 2017-04-27 criteria provided, single submitter clinical testing This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance.
Center for Genomics, Ann and Robert H. Lurie Children's Hospital of Chicago RCV000629187 SCV002495830 uncertain significance Chédiak-Higashi syndrome 2021-05-11 criteria provided, single submitter clinical testing LYST NM_000081.3 exon 35 p.Val2936Ile (c.8806G>A): This variant has not been reported in the literature but is present in 0.08% (57/68026) of European alleles in the Genome Aggregation Database (https://gnomad.broadinstitute.org/variant/1-235731173-C-T?dataset=gnomad_r3). This variant is present in ClinVar (Variation ID:525145). Evolutionary conservation and computational predictive tools suggest that this variant may not impact the protein. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain.
Genome Diagnostics Laboratory, The Hospital for Sick Children RCV002263841 SCV002543673 uncertain significance Autoinflammatory syndrome 2016-12-12 criteria provided, single submitter clinical testing
Ambry Genetics RCV002528824 SCV003549375 uncertain significance Inborn genetic diseases 2021-06-06 criteria provided, single submitter clinical testing (Gorski, 2019; Leinoe, 2017) Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
Revvity Omics, Revvity RCV000629187 SCV003815320 uncertain significance Chédiak-Higashi syndrome 2019-11-05 criteria provided, single submitter clinical testing
CeGaT Center for Human Genetics Tuebingen RCV000658240 SCV004033008 likely benign not provided 2023-08-01 criteria provided, single submitter clinical testing LYST: BP4

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.